AP Biosciences Inc (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 168.00
-0.50 (-0.30%)
At close: Feb 11, 2026
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 14.38 billion as of February 11, 2026. Its market cap has increased by 222.82% in one year.
Market Cap
14.38B
Enterprise Value
13.16B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
168.00
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 14.38B, an increase of 182.13%. That is a compound annual growth rate of 49.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 14.42B | -5.88% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaris Group | 22.54B |
| Sunmax Biotechnology | 21.30B |
| EirGenix | 18.46B |
| TaiMed Biologics | 14.53B |
| Ever Supreme Bio Technology | 13.31B |
| Tanvex BioPharma | 12.98B |
| Medigen Vaccine Biologics | 11.80B |
| TCM Biotech International | 10.72B |